<DOC>
	<DOCNO>NCT00653653</DOCNO>
	<brief_summary>Using prospective study design two three month period ( genotyping ) patient self-monitor health status possible medical event hypothesize show patient medication alter fit genetic status and/or medication alter inherent interaction potential less recordable event genotyping medical analysis . It well know ADRs ( recordable adverse event medication ) responsible large number death hospitalization . Furthermore well record genotyping individual cytochrome P450 enzymes ( 2D6 , 2C9 , 2C19 , among others ) directly relate metabolic phenotype - fast metabolisers , slow metabolisers , intermediate normal metabolisers . These differ phenotype alter metabolism many medication number retrospective clinical trail show ADRs effect reduced/bettered genotyping alteration medication .</brief_summary>
	<brief_title>Medication Optimisation Reducing Events Private Practice Setting</brief_title>
	<detailed_description />
	<criteria>old 18 year demented 1 documented event previous 6 month . one medication multimorbid demented life expectancy le 1 year heart attack within last 6 month MarcumarÂ® Therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>pharmacogenetics</keyword>
	<keyword>pharmacoeconomics</keyword>
	<keyword>adverse event</keyword>
	<keyword>drug metabolism</keyword>
</DOC>